A review of Leishmaniasis in Eastern Africa

Peter K. Ngure , Albert Kimutai , Zipporah W. Ng'ang'a , Geoffrey Rukunga , Willy K. Tonui
{"title":"A review of Leishmaniasis in Eastern Africa","authors":"Peter K. Ngure ,&nbsp;Albert Kimutai ,&nbsp;Zipporah W. Ng'ang'a ,&nbsp;Geoffrey Rukunga ,&nbsp;Willy K. Tonui","doi":"10.1016/S1007-4376(09)60032-0","DOIUrl":null,"url":null,"abstract":"<div><p>The review presents the epidemiology of leishmaniasis in the Eastern Africa region. We searched PUB MED and MEDLINE with several key words-namely, “leishmaniasis”;“cutaneous”, “diffuse cutaneous”, “mucosal”, and “visceral leishmaniasis”; “kala azar”, and “post kala azar dermal leishmaniasis”, -for recent clinical and basic science articles related to leishmaniasis in countries in the Eastern Africa region. Poverty, wars, conflicts and migration have significantly aggravated leishmaniases in Eastern Africa. Of particular concern is the increasing incidence of <em>Leishmania</em>-HIV co-infection in Ethiopia where 20∼40% of the persons affected by visceral leishmaniasis are HIV-co-infected. Sudan has the highest prevalence rate of post kala-azar dermal leishmaniasis(PKDL) in the world, a skin complication of visceral leishmaniasis(VL) that mainly afflicts children below age ten. In view of its spread to previously non-endemic areas and an increase in imported cases, leishmaniasis in Eastern Africa should be considered a health emergency.</p></div>","PeriodicalId":100807,"journal":{"name":"Journal of Nanjing Medical University","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1007-4376(09)60032-0","citationCount":"42","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nanjing Medical University","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1007437609600320","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 42

Abstract

The review presents the epidemiology of leishmaniasis in the Eastern Africa region. We searched PUB MED and MEDLINE with several key words-namely, “leishmaniasis”;“cutaneous”, “diffuse cutaneous”, “mucosal”, and “visceral leishmaniasis”; “kala azar”, and “post kala azar dermal leishmaniasis”, -for recent clinical and basic science articles related to leishmaniasis in countries in the Eastern Africa region. Poverty, wars, conflicts and migration have significantly aggravated leishmaniases in Eastern Africa. Of particular concern is the increasing incidence of Leishmania-HIV co-infection in Ethiopia where 20∼40% of the persons affected by visceral leishmaniasis are HIV-co-infected. Sudan has the highest prevalence rate of post kala-azar dermal leishmaniasis(PKDL) in the world, a skin complication of visceral leishmaniasis(VL) that mainly afflicts children below age ten. In view of its spread to previously non-endemic areas and an increase in imported cases, leishmaniasis in Eastern Africa should be considered a health emergency.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
东非利什曼病综述
本综述介绍了东非地区利什曼病的流行病学情况。我们用几个关键词检索PUB MED和MEDLINE,即“利什曼病”、“皮肤”、“弥漫性皮肤”、“粘膜”和“内脏利什曼病”;“黑热病”和“黑热病后皮肤利什曼病”-用于最近与东非区域各国利什曼病有关的临床和基础科学文章。贫穷、战争、冲突和移民严重加剧了东非的利什曼病。特别令人关切的是,在埃塞俄比亚,利什曼-艾滋病毒合并感染的发病率不断上升,其中20% ~ 40%的内脏利什曼病患者同时感染艾滋病毒。苏丹是世界上黑热病后皮肤利什曼病(PKDL)患病率最高的国家,这是内脏利什曼病(VL)的一种皮肤并发症,主要影响10岁以下儿童。鉴于利什曼病在以前非流行地区的蔓延和输入病例的增加,应将东非的利什曼病视为一种卫生紧急情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Effects of sevoflurane on left ventricular function by speckle-tracking echocardiography in coronary bypass patients: A randomized trial Phosphorylated protein chip combined with artificial intelligence tools for precise drug screening Upregulation of α-ENaC induces pancreatic β-cell dysfunction, ER stress, and SIRT2 degradation Irisin/BDNF signaling in the muscle-brain axis and circadian system: a review ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1